These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23757504)

  • 1. Developing high-fidelity hepatotoxicity models from pluripotent stem cells.
    Medine CN; Lucendo-Villarin B; Storck C; Wang F; Szkolnicka D; Khan F; Pernagallo S; Black JR; Marriage HM; Ross JA; Bradley M; Iredale JP; Flint O; Hay DC
    Stem Cells Transl Med; 2013 Jul; 2(7):505-9. PubMed ID: 23757504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening.
    Greenhough S; Medine CN; Hay DC
    Toxicology; 2010 Dec; 278(3):250-5. PubMed ID: 20674645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells.
    Asplund A; Pradip A; van Giezen M; Aspegren A; Choukair H; Rehnström M; Jacobsson S; Ghosheh N; El Hajjam D; Holmgren S; Larsson S; Benecke J; Butron M; Wigander A; Noaksson K; Sartipy P; Björquist P; Edsbagge J; Küppers-Munther B
    Stem Cell Rev Rep; 2016 Feb; 12(1):90-104. PubMed ID: 26385115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays.
    Nakamura N; Saeki K; Mitsumoto M; Matsuyama S; Nishio M; Saeki K; Hasegawa M; Miyagawa Y; Ohkita H; Kiyokawa N; Toyoda M; Akutsu H; Umezawa A; Yuo A
    Cell Reprogram; 2012 Apr; 14(2):171-85. PubMed ID: 22384928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate prediction of drug-induced liver injury using stem cell-derived populations.
    Szkolnicka D; Farnworth SL; Lucendo-Villarin B; Storck C; Zhou W; Iredale JP; Flint O; Hay DC
    Stem Cells Transl Med; 2014 Feb; 3(2):141-8. PubMed ID: 24375539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and expansion of human pluripotent stem cell-derived hepatic progenitor cells by growth factor defined serum-free culture conditions.
    Fukuda T; Takayama K; Hirata M; Liu YJ; Yanagihara K; Suga M; Mizuguchi H; Furue MK
    Exp Cell Res; 2017 Mar; 352(2):333-345. PubMed ID: 28215634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining stem cell-derived hepatocytes with impedance sensing to better predict human drug toxicity.
    Zhou W; Graham K; Lucendo-Villarin B; Flint O; Hay DC; Bagnaninchi P
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):77-83. PubMed ID: 30572740
    [No Abstract]   [Full Text] [Related]  

  • 9. Aggregate culture of human embryonic stem cell-derived hepatocytes in suspension are an improved in vitro model for drug metabolism and toxicity testing.
    Sengupta S; Johnson BP; Swanson SA; Stewart R; Bradfield CA; Thomson JA
    Toxicol Sci; 2014 Jul; 140(1):236-45. PubMed ID: 24752503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening.
    Takayama K; Mizuguchi H
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):12-20. PubMed ID: 28012798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.
    Wang Z; Li W; Jing H; Ding M; Fu G; Yuan T; Huang W; Dai M; Tang D; Zeng M; Chen Y; Zhang H; Zhu X; Peng Y; Li Q; Yu WF; Yan HX; Zhai B
    Theranostics; 2019; 9(22):6690-6705. PubMed ID: 31588244
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemically induced hepatotoxicity in human stem cell-induced hepatocytes compared with primary hepatocytes and HepG2.
    Kang SJ; Lee HM; Park YI; Yi H; Lee H; So B; Song JY; Kang HG
    Cell Biol Toxicol; 2016 Oct; 32(5):403-17. PubMed ID: 27287938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.
    Goldring C; Antoine DJ; Bonner F; Crozier J; Denning C; Fontana RJ; Hanley NA; Hay DC; Ingelman-Sundberg M; Juhila S; Kitteringham N; Silva-Lima B; Norris A; Pridgeon C; Ross JA; Young RS; Tagle D; Tornesi B; van de Water B; Weaver RJ; Zhang F; Park BK
    Hepatology; 2017 Feb; 65(2):710-721. PubMed ID: 27775817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes.
    Kim JH; Wang M; Lee J; Park HJ; Han C; Hong HS; Kim JS; An GH; Park K; Park HK; Zhu SF; Sun XB; Kim JH; Woo DH
    Cell Biol Toxicol; 2018 Feb; 34(1):51-64. PubMed ID: 28382404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-D culture and endothelial cells improve maturity of human pluripotent stem cell-derived hepatocytes.
    Ardalani H; Sengupta S; Harms V; Vickerman V; Thomson JA; Murphy WL
    Acta Biomater; 2019 Sep; 95():371-381. PubMed ID: 31362140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
    Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
    Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?
    Kia R; Sison RL; Heslop J; Kitteringham NR; Hanley N; Mills JS; Park BK; Goldring CE
    Br J Clin Pharmacol; 2013 Apr; 75(4):885-96. PubMed ID: 22703588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.
    Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH
    Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.
    Shinozawa T; Kimura M; Cai Y; Saiki N; Yoneyama Y; Ouchi R; Koike H; Maezawa M; Zhang RR; Dunn A; Ferguson A; Togo S; Lewis K; Thompson WL; Asai A; Takebe T
    Gastroenterology; 2021 Feb; 160(3):831-846.e10. PubMed ID: 33039464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes.
    Iwamuro M; Shiraha H; Nakaji S; Furutani M; Kobayashi N; Takaki A; Yamamoto K
    Biomed Eng Online; 2012 Dec; 11():93. PubMed ID: 23217363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.